BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 23830991)

  • 1. Synergistic apoptotic effect of crocin and cisplatin on osteosarcoma cells via caspase induced apoptosis.
    Li X; Huang T; Jiang G; Gong W; Qian H; Zou C
    Toxicol Lett; 2013 Aug; 221(3):197-204. PubMed ID: 23830991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteasome inhibitor MG132 enhances TRAIL-induced apoptosis and inhibits invasion of human osteosarcoma OS732 cells.
    Li X; Huang T; Jiang G; Gong W; Qian H; Zou C
    Biochem Biophys Res Commun; 2013 Sep; 439(2):179-86. PubMed ID: 23994633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient killing effect of osteosarcoma cells by cinobufacini and cisplatin in combination.
    Huang T; Gong WH; Li XC; Zou CP; Jiang GJ; Li XH; Qian H
    Asian Pac J Cancer Prev; 2012; 13(6):2847-51. PubMed ID: 22938471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cisplatin (CDDP) specifically induces apoptosis via sequential activation of caspase-8, -3 and -6 in osteosarcoma.
    Seki K; Yoshikawa H; Shiiki K; Hamada Y; Akamatsu N; Tasaka K
    Cancer Chemother Pharmacol; 2000; 45(3):199-206. PubMed ID: 10663637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of nuclear factor-κB by dehydroxymethylepoxyquinomicin induces schedule-dependent chemosensitivity to anticancer drugs and enhances chemoinduced apoptosis in osteosarcoma cells.
    Castro-Gamero AM; Borges KS; da Silva Silveira V; Lira RC; de Paula Gomes Queiroz R; Valera FC; Scrideli CA; Umezawa K; Tone LG
    Anticancer Drugs; 2012 Jul; 23(6):638-50. PubMed ID: 22382389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tranilast enhances the effect of anticancer agents in osteosarcoma.
    Nakashima T; Nagano S; Setoguchi T; Sasaki H; Saitoh Y; Maeda S; Komiya S; Taniguchi N
    Oncol Rep; 2019 Jul; 42(1):176-188. PubMed ID: 31059083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin inhibits growth and sensitizes osteosarcoma cell lines to cisplatin through cell cycle modulation.
    Quattrini I; Conti A; Pazzaglia L; Novello C; Ferrari S; Picci P; Benassi MS
    Oncol Rep; 2014 Jan; 31(1):370-5. PubMed ID: 24253938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Viability inhibition effect of gambogic acid combined with cisplatin on osteosarcoma cells via mitochondria-independent apoptotic pathway.
    Zhao W; You CC; Zhuang JP; Zu JN; Chi ZY; Xu GP; Yan JL
    Mol Cell Biochem; 2013 Oct; 382(1-2):243-52. PubMed ID: 23812885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic inhibitory effects of capsaicin combined with cisplatin on human osteosarcoma in culture and in xenografts.
    Wang Y; Deng X; Yu C; Zhao G; Zhou J; Zhang G; Li M; Jiang D; Quan Z; Zhang Y
    J Exp Clin Cancer Res; 2018 Oct; 37(1):251. PubMed ID: 30326933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of osteosarcoma cell sensitivity to cisplatin using paclitaxel in the presence of hyperthermia.
    Huang T; Gong W; Li X; Zou C; Jiang G; Li X; Feng D
    Int J Hyperthermia; 2013 May; 29(3):248-55. PubMed ID: 23527624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of apoptosis in osteogenic sarcoma cells by combination of tumor necrosis factor-related apoptosis inducing ligand and chemotherapeutic agents.
    Sun J; Fu ZM; Fang CQ; Li JH
    Chin Med J (Engl); 2007 Mar; 120(5):400-4. PubMed ID: 17376311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of G2/M phase cell cycle arrest and apoptosis by ginsenoside Rf in human osteosarcoma MG‑63 cells through the mitochondrial pathway.
    Shangguan WJ; Li H; Zhang YH
    Oncol Rep; 2014 Jan; 31(1):305-13. PubMed ID: 24173574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemosensitive effects of Astragaloside IV in osteosarcoma cells via induction of apoptosis and regulation of caspase-dependent Fas/FasL signaling.
    Hu T; Fei Z; Wei N
    Pharmacol Rep; 2017 Dec; 69(6):1159-1164. PubMed ID: 29128795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The combination of crocin with cisplatin suppresses growth of gastric carcinoma cell line BGC-823 and promotes cell apoptosis.
    Luo Y; Cui S; Tang F; Shen C; Qi Y; Lu D; Ma L; Yang Y; Li Y; Chen R; Ri-Li GE
    Pak J Pharm Sci; 2017 Sep; 30(5):1629-1634. PubMed ID: 29084683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteosarcoma cells with genetic signatures of BRCAness are susceptible to the PARP inhibitor talazoparib alone or in combination with chemotherapeutics.
    Engert F; Kovac M; Baumhoer D; Nathrath M; Fulda S
    Oncotarget; 2017 Jul; 8(30):48794-48806. PubMed ID: 27447864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gadolinium chloride elicits apoptosis in human osteosarcoma U-2 OS cells through extrinsic signaling, intrinsic pathway and endoplasmic reticulum stress.
    Tsai YF; Huang CW; Chiang JH; Tsai FJ; Hsu YM; Lu CC; Hsiao CY; Yang JS
    Oncol Rep; 2016 Dec; 36(6):3421-3426. PubMed ID: 27748868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Caffeine citrate enhanced cisplatin antitumor effects in osteosarcoma and fibrosarcoma in vitro and in vivo.
    Abe K; Yamamoto N; Hayashi K; Takeuchi A; Tsuchiya H
    BMC Cancer; 2019 Jul; 19(1):689. PubMed ID: 31307409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitizing osteosarcoma stem cells to doxorubicin-induced apoptosis through retention of doxorubicin and modulation of apoptotic-related proteins.
    Gonçalves C; Martins-Neves SR; Paiva-Oliveira D; Oliveira VE; Fontes-Ribeiro C; Gomes CM
    Life Sci; 2015 Jun; 130():47-56. PubMed ID: 25818183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Nitidine chloride-induced apoptosis of human osteosarcoma cells and its mechanism].
    Xu Q; Li ZX; Ye ZM
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Feb; 31(2):361-4. PubMed ID: 21354931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oleandrin synergizes with cisplatin in human osteosarcoma cells by enhancing cell apoptosis through activation of the p38 MAPK signaling pathway.
    Yong L; Ma Y; Zhu B; Liu X; Wang P; Liang C; He G; Zhao Z; Liu Z; Liu X
    Cancer Chemother Pharmacol; 2018 Dec; 82(6):1009-1020. PubMed ID: 30267330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.